Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v6-EN
Language English English
Date Updated 2019-09-18 2019-08-23
Drug Identification Number 02373068 02373068
Brand name GD-LATANOPROST/TIMOLOL GD-LATANOPROST/TIMOLOL
Common or Proper name GD/LATANOPROST/TIMOLOL GD/LATANOPROST/TIMOLOL
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients TIMOLOL LATANOPROST TIMOLOL LATANOPROST
Strength(s) 5MG 50MCG 5MG 50MCG
Dosage form(s) SOLUTION SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 2.5ml 2.5ml
ATC code S01ED S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2019-08-22 2019-08-22
Estimated end date 2019-09-20 2019-09-20
Actual end date 2019-09-17
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments